Reuters logo
BRIEF-Prometic Life Sciences Inc plasminogen administration shown to reduce acute lung injury
May 8, 2017 / 11:21 AM / in 5 months

BRIEF-Prometic Life Sciences Inc plasminogen administration shown to reduce acute lung injury

May 8 (Reuters) - Prometic Life Sciences Inc:

* Prometic Life Sciences Inc - plasminogen administration shown to reduce acute lung injury (“ali”) in an acute pancreatitis model

* Prometic Life Sciences Inc - PBI-4050 is safe and well tolerated and shows evidence of benefit in idiopathic pulmonary fibrosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below